Telo Genomics (TDSGF, $0.09) was a top loser over the last three months, falling to $0.09 per share. A.I.dvisor analyzed 420 stocks in the Medical Specialties Industry for the 3-month period ending November 15, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.